Radioimmunotherapy versus traditional, nontargeted forms of systemic cancer treatment.
Behr
T M
TM
Béhé
M P
MP
D000906:Antibodies / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D019653:Myeloablative Agonists / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use; D016499:Radioimmunotherapy / Q000639:trends*; D015996:Survival Rate
D000906:Antibodies; D019653:Myeloablative Agonists; D010455:Peptides